Friday, August 03, 2018 3:59:32 PM
Mr. Nerlino has been a business consultant engaged in providing introductions of Investment Banking and networking services to both public and private companies.
Starting in 1995, Mr. Nerlino has been a business consultant engaged in providing introductions of Investment Banking and networking services to both public and private companies. From 1996 until 2001, he was the Chairman, CEO and President of American Sports History, Inc., a public company that was in publications and several sports related businesses. Prior to 1995, Mr. Nerlino affiliated himself as an investment broker and executive officer at various top Wall Street investment banking firms. He was an Investment Broker at Merrill Lynch, VP at Paine Webber, and was Senior Vice President at Oppenheimer & Co. Mr. Nerlino was Associate Director/Partner at Bear Stearns where he handled over 1500 accounts totaling more than one Billion in assets, which eventually grew to almost five Billion. He was the highest retail producer in Bear Stearns history.
Mr. Nerlino represented the Catholic Religious Community clients and later personally assisted in the development of an Investment Advisory Service, which directed investment expertise and education to other Catholic organizations throughout the world. During this time, he also participated as the primary liaison/speaker at seminar meetings about investment benefits to religious organizations worldwide. While at Bear Stearns, and as chief liaison, his speech in Rome, Italy resulted in a large international client base for both the firm and the Investment Advisory Service, which gave him an opportunity to meet with clients and Vatican officials regarding the partnership between the Advisory and Bear Stearns. He continues to participate as a consultant in providing investment banking and networking introductions to a group of personally selected, private and public companies, some of which he serves as a member on their Board of Directors. Mr. Nerlino is a member of the Professional Alliance of Morgan Stanley, Smith Barney.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM